Single Life Time Cytological Screening in High Risk Women as an Economical and Feasible Approach to Control Cervical Cancer in Developing Countries Like India

  • Misra, Jata Shankar (Department of Pathology, Era's Lucknow Medical College, KG Medical University) ;
  • Srivastava, Anand Narain (Department of Pathology, Era's Lucknow Medical College, KG Medical University) ;
  • Das, Vinita (Department of Obstetrics and Gynaecology, KG Medical University)
  • Published : 2015.03.04


In view of funding crunches and inadequate manpower in cytology in developing countries like India, single lifetime screening for cervical cancer has been suggested. In this study, an attempt was made to cscreening to make it more effective for early detection. Cytological data were derived from the ongoing routine cervical cytology screening program for women attending Gynaecology Out Patient Department of Queen Mary's Hospital of K.G.Medical University, Lucknow, India during a span of 35 years (April 1971 - December 2005). Cervical smears in a total of 38,256 women were cytologically evaluated. The frequencies of squamous intraepithelial lesions of cervix (SIL) and carcinoma cervix were found to be 7.0% and 0.6%, respectively, in the series. Predisposing factors related to cervical carcinogenesis were analyzed in detail to establish the most vulnerable groups of women for single life time screening. The incidence of SIL and carcinoma cervix was found to be maximal in women above the age of 40 years irrespective of parity and in multiparous women (with three or more children) irrespective of age. The incidence of cervical cytopathologies was significantly higher in symptomatic women, the frequency of SIL being alarmingly higher in women complaining of contact bleeding and that of carcinoma cervix in older women with postmenopausal bleeding. It is consequently felt that single life time screening must include the three groups of women delineated above. Such selective screening appears to be the most economical, cost effective and feasible approach to affordably control the menace of cervical cancer in developing countries like India.


  1. Abdullah F, Su TT (2010). Enhancement of cervical cancer screening program in Malaysia: A qualitative study. Asian Pac J Cancer Prev, 11, 1359-66.
  2. Alarcón-Romero Ldel C, Illades-Aguiar B, Flores-Alfaro E, et al (2009). AgNOR pleomorphism association with squamous intraepithelial lesions and invasive carcinoma with HPV infection. Salud Publica Mex, 51, 134-140.
  3. Baker, M, Guler, H, Evili, F, Demiel, G. et al. (2013). Determining knowledge and attitude regarding gynaecological cancer prevention. Asian Pac J Cancer Prev, 14, 6055-9
  4. Budkaew J, Chumorthavy P, (2014). Factors associated with decision to attend cervical cancer screening among women aged 30-60 years in Chatapadund Contracting Medical Unit, Thailand. Asian Pac J Cancer Prev, 15, 4903-7.
  5. Domta B, Begum S, Nair S, Mali BN, et al (2012). Awareness of cervical cancer among couples in slum areas of Mumbai. Asian Pac J Cancer Prev, 13, 4901-3.
  6. D'Souza, ND, Murthy NS, Aras RY (2013). Projection of cancer incident cases for India-2026. Asian Pac J Cancer Prev, 14, 4379-86.
  7. Karim Zarchi, M, Akhvan, A, Gholmi H, et al (2010). Evaluation of cancer risk factors in women referred to Yazd Iran hospital from 2002-2009. Asian Pac J Cancer Prev, 11, 537-8.
  8. Kumar Y, Mishra G, Gupta S, Shahtri S, (2011). Cancer screening for women living in urban slums, acceptance and satisfaction. Asian Pac J Cancer Prev, 12,1681-5
  9. Lee CH, Peng CY, Li RN, et al (2014). Risk evaluation for the development of cervical intraepithelial neoplasia: development and validation of risk-scoring schemes. Int J Cancer, 10, 1002
  10. Lynge E, Rygaard C, Baillet MV, et al (2014). Cervical cancer screening at crossroads. APMIS, 122, 667-73.
  11. Miller AB (2000). Report on consensus conference on cervical cancer screening and management. Int J Cancer, 86, 440-447.<440::AID-IJC22>3.0.CO;2-A
  12. Misra JS, Gupta HP, Das V (2004). Assessing the feasibility of single life time screening pap smear evaluation between 41-45 years of age as strategy for cervical cancer control in developing countries: Our 32 years of experience of hospital based routine cytological screening. Diag Cytopath, 31, 3769.
  13. Misra JS, Srivastava S, Singh U, Srivastava AN (2007). Risk factors and strategies for control of carcinoma cervix in India. Hospital based cytological screening of 35 years. Ind J Cancer, 48, 155-9.
  14. Misra JS, Chhavi Singh M, Srivastava AN, Das V (2009). Assessment of potential of AgNOR counts as tumor markers in cervical carciogenesis. Diag Cytopath, 36, 194-5.
  15. Prabhakar K (1992). Strategy for control of cervical cancer in India. Acta University Tamperensis. Ser. A:334:1-12.
  16. Rowlands DC (1988). Nucleolar organizing regions in cervical intraepithelial neoplasia. J Clin Path, 41,1200-2
  17. Srivastava AN, Srivastava S, Bansal C, Misra JS (2013). Diagnostic importance of AgNOR pleomorphism in cervical carcinogenesis. Ecancermedicalscience, 7, 287.
  18. Thulaseedharan JV, Malila N, Hukama M, et al (2012) Sociodemographic and reproductive risk factors for cervical cancer- A large prospective cohort study from rural India. Asian Pac J Cancer Prev, 13, 2991-5.
  19. Yasmeen J, Kureshi MA, Manzoor A, et al (2010). A community based screening of cervical cancer in a low prevalence area of India: A cross sectional study. Asian Pac J Cancer Prev, 11, 231-4.

Cited by

  1. Alantolactone induces apoptosis of human cervical cancer cells via reactive oxygen species generation, glutathione depletion and inhibition of the Bcl-2/Bax signaling pathway vol.11, pp.6, 2016,